KORRO BIO
LIVE

Serial Number

97980286

Owner

Korro Bio, Inc.

Attorney

Tiffany D. Gehrke

Filing Date

Jul 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

KORRO BIO Trademark

Serial Number: 97980286 • Registration: 7907662

KORRO BIO is a trademark filed by Korro Bio, Inc. on July 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Korro Bio, Inc. (12 trademarks)

Suite 6-401
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

July 7, 2022

Registration Date

August 19, 2025

Published for Opposition

November 7, 2023

Goods & Services

Pharmaceutical preparations for the treatment of rare genetic diseases; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceutical preparations containing biomedical compounds comprised of ribonucleic acid polymers for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; RNA therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Nucleic acid therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for use in RNA editing; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for use in base editing; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for use as RNA therapeutic for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, nucleic acid therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceuticals, namely, bio-pharmaceutical preparations for the treatment of rare diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 7, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 7, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 7, 2025 REAP
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 28, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 28, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 9, 2025 SUPC
DIVISIONAL PROCESSING COMPLETE
Jul 9, 2025 DPCC
USE AMENDMENT FILED
Jun 24, 2025 IUAF
DIVISIONAL REQUEST RECEIVED
Jun 24, 2025 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jun 24, 2025 ERTD
SOU TEAS EXTENSION RECEIVED
Jun 24, 2025 EEXT
TEAS STATEMENT OF USE RECEIVED
Jun 24, 2025 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 3, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 3, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 3, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 25, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jan 24, 2025 EX2G
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jan 7, 2025 TPEX
NOTICE OF REVIVAL - E-MAILED
Jan 7, 2025 NREV
PETITION TO REVIVE-GRANTED
Jan 7, 2025 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 7, 2025 PROA
SOU EXTENSION 2 FILED
Jan 2, 2025 EXT2
CORRECTED NOA E-MAILED
Aug 20, 2024 NOAC
DIVISIONAL PROCESSING COMPLETE
Aug 20, 2024 DPCC
DIVISIONAL REQUEST RECEIVED
Aug 8, 2024 DRRR
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 2, 2024 AITU
TEAS REQUEST TO DIVIDE RECEIVED
Jun 13, 2024 ERTD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 11, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jun 11, 2024 EX1G
SOU EXTENSION 1 FILED
Jun 11, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 11, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 2, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 7, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 18, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 30, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 28, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 28, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 31, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 31, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 31, 2023 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 25, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 25, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 25, 2023 REAP
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 15, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 9, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2023 CNSA
ASSIGNED TO EXAMINER
Apr 20, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 26, 2022 NWOS
NEW APPLICATION ENTERED
Jul 11, 2022 NWAP